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Abstract 
BACKGROUND: Neonatal renal vein thrombosis is the most common vascular condition in the newborn kidney, 
which could lead to serious complication in infants. 
CASE REPORT: We report a case of the unilateral renal vein and inferior vena cava thrombosis, presented with 
gross hematuria and thrombocytopenia in a neonate. The neonate was a macrosomic male born to a mother with 
hyperglycemia in pregnancy. The baby was born with perinatal asphyxia and early neonatal infection and massive 
hematuria. Clinical and laboratory examination showed enlarged kidney having corticomedullary differentiation 
diminished and azotemia. Diagnosis of renal vein thrombosis was suspected by renal ultrasound and confirmed 
by magnetic urography. Prothrombotic risk factors were evaluated. The child is being managed conservatively. 
Measures aimed at the prevention of end-stage renal disease because of its poor outcome were highlighted. 
Despite anticoagulant therapy, the right kidney developed areas of scarring and then atrophy.  
CONCLUSION: In this work, we present a patient with multiple entities in the aetiology of non-catheter induced 
renal and vena cava thrombosis in a neonate. Clinicians should suspect renal vein thrombosis in neonates when 
presented with early postnatal gross hematuria, palpable abdominal mass and thrombopenia. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Renal vein thrombosis is a rare condition in 
neonates, usually as a consequence of perinatal 
asphyxia, maternal diabetes mellitus, hypovolemia, 
hyperosmolarity and coagulopathies. Less often the 
cause of renal vein thrombosis is congenital heart 
disease, disseminated coagulopathy, prematurity and 
infection. External risk factors include central arterial 
and venous catheters. Neonates are most susceptible 
age group for renal vein thrombosis; premature infants 
are a most susceptible neonatal group. 
Neonates are most susceptible for renal vein 
thrombosis due to the physiology of neonatal 
hemostasis and lower levels of anticoagulants also 
low levels of fibrinolytic components. The prevalence 
is 2.2 per 100,000 lives and around 0.5 per 1000 
newborn babies treated in NICU. The prevalence of 
inferior vena cava thrombosis in neonates is the main 
symptoms are gross hematuria, papabile abdominal 
mass due to enlarged kidney and thrombocytopenia.  
Diagnosis is suspected based on specific 
symptoms, ultrasonography and additional imaging 
studies such as venography, CT and MR urography 
confirm the diagnosis. Aetiology of hypercoagulable 
state should be searched for and treated. Inherited 
prothrombotic anomalies have been reported in 
association with neonatal renal vein thrombosis. Signs 
and symptoms of acute kidney injury should be 
monitored, and long-term follow up is mandatory. We 
present a patient with multiple entities in the aetiology 
of non-catheter induced renal and vena cava 
thrombosis in a neonate. 
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Case report 
 
We report a case of the unilateral renal vein 
and inferior vena cava thrombosis, presented with 
gross hematuria and thrombocytopenia in a neonate. 
The neonate was a macrosomic male, born to a 
mother with hyperglycemia in pregnancy. The family 
history was negative for coagulopathies. He was born 
in 40
th
-week gestation with perinatal asphyxia, Apgar 
scores were 6/7/7. The baby was large for gestational 
age; the birth weight was 5270 gr. He was plethoric, 
had hemoconcentration, polycythemia and had signs 
early neonatal sepsis (leukocytosis, thrombopenia) 
with massive hematuria. Fluid management and 
antibiotic treatment were started. Initial treatment 
included broad-spectrum antibiotics and anticoagulant 
therapy, with careful attention to fluid balance and 
nutrition.  
 
Figure 1: Swollen right kidney and normal sized left kidney in the 
initial phase of renal vein thrombosis 
 
Diagnosis of renal vein thrombosis was 
suspected by renal ultrasound and confirmed by 
magnetic urography. Abdominal ultrasound showed 
enlarged right kidney having corticomedullary 
differentiation diminished (right kidney 70 x 48 mm, 
left kidney 58 x 30 mm), normal values of serum 
creatinine (49 micromoles/l) and uric acid (179.5 
micromole/l). Magnetic urography showed enlarged 
edematous right kidney with a subcapsular 
hematoma. Thrombus is seen in the right renal vein 
and vena cava inferior (25 mm) distally from the renal 
vein. Prothrombotic risk factors were evaluated.  
Protein C and antithrombin III activity were 
normal for the age. Thrombophilic genes were tested, 
and heterozygosity of FBG 455 G/A, MTHFR C677T 
and MTRR A66G polymorphisms was found. 
Mutations causing arterial and thrombotic anomalies 
were tested. Heterozygous mutation C677T was 
found in the methylene tetra hydro folate reductase 
gene (MTHFR), a heterozygous mutation in the LTA 
and 455 G>A in the B-fibrinogen gene were found.  
The child is being managed conservatively. 
Anticoagulant therapy continued with subcutaneous 
low molecular mass heparin (LMWH) twice a day. 
Laboratory tests of kidney function showed a transient 
rise in serum creatinine and urea, proteinuria, and 
hematuria. Inflammatory parameters gradually 
normalised and the subsequent blood culture was 
negative.  
 
Figure 2: Longitudinal ultrasound scan shows a swollen right kidney 
with a suprarenal anechoic cyst-like lesion and hyperechoic 
intramedullary streaks in the initial phase of renal vein thrombosis 
 
Afterwards, the boy has been attending the 
outpatient clinic. Anticoagulant therapy continued with 
subcutaneous low molecular mass heparin (LMWH) 
for three months and subsequently discontinued when 
the coagulation profile was normal. Despite 
anticoagulant therapy, the right kidney developed 
areas of scarring and then atrophy. Kidney volumes 
after 4 months of treatment showed right kidney 34 x 
20 mm and left kidney measuring 68 x 35 mm). His 
follow-up laboratory results showed normal kidney 
function. At the age of 8 months, DMSA scan showed 
no renal tissue on the right side, as a consequence of 
renal atrophy.  
 
Figure 3: Magnetic resonance- magnetic urography in the early 
phase of renal and inferior vena cava thrombosis 
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Discussion 
 
We present a rare case of non-catheter 
induced inferior cava and renal vein thrombosis in a 
neonate. Factors predisposing this neonate to RVT 
include maternal diabetes, early onset infection and 
complicated labour. The neonate was with no family 
history of thrombotic disorders or fetal losses, 
although the child was found to have prothrombotic 
risk factors. 
 
Figure 4: Small right kidney and compensatory hypertrophied left 
kidney, five months after birth 
 
Neonates are prone to thrombosis in 
comparison to other age groups. This is because they 
have decreased levels of anticoagulants and 
fibrinolytic components. Factors predisposing to 
neonatal venous thrombosis are genetic and 
environmental. Maternal factors predisposing vein 
thrombosis in neonates are maternal hyperglycemia 
and diabetes, preeclampsia, chorioamnionitis and 
autoimmune diseases. Early neonatal infection, 
perinatal asphyxia, hypovolemia and 
hemoconcentration due to dehydration, polycythemia, 
hypercoagulability lead to renal vein thrombosis [1]. 
The most important cause is central arterial and 
venous catheters, especially umbilical venous 
catheterisation, reporting 75-95% of thrombotic events 
were catheter-related [2].  
A Dutch study refers to 66% of all thrombi in 
catheter-induced thrombosis was found in the inferior 
vena cava, but they didn’t find inferior vena cava 
thrombi in the non-catheter related thrombosis [3]. 
Studies reporting non-catheter induced inferior vena 
cava thrombosis are rare and usually report an 
association with extensive renal vein thrombosis, 
inferior vena cava anomalies or external pressure. 
Inherited prothrombotic anomalies have been reported 
in association with neonatal renal vein thrombosis. 
Studies report prothrombic anomalies associated with 
renal vein thrombosis but less often with inferior vena 
cava thrombosis [4]. Our patient had a rare set of 
genetic and external factors leading to renal vein 
thrombosis but also inferior vena cava thrombosis.  
 Symptoms usually include gross hematuria, 
thrombopenia, palpable abdominal mass and renal 
failure. They frequently overlap with the signs and 
symptoms of neonatal infection and shock. Clinicians 
need to monitor closely to prevent renal damage. The 
diagnosis is suspected on renal ultrasonography 
(showing renal enlargement) but proven with 
computed tomography or magnetic urography and 
radioisotope scans [5] [6]. Treatment of neonatal vein 
thrombosis remains controversial, and the benefits 
and the possible side effects need to be measured. 
Surgical intervention is not indicated in the early 
phases of renal vein thrombosis [7]. Thrombectomy is 
rarely possible due to the small blood vessel calibre. 
Treatment modalities include thrombolysis using 
heparin, urokinase and recombinant plasminogen 
activator (r-tPA) [8] [9] [10] [11]. Large randomised 
controlled studies using anticoagulant treatment in 
newborns are still missing. Low molecular weight 
heparin (LMWH) is mostly used as an anticoagulant 
agent in infants due to fewer side effects and the easy 
way of subcutaneous administration [12] [13] [14]. 
 Although different modalities have been used 
treating neonatal vein thrombosis, the outcome is 
often unsatisfactory, and renal damage and renal loss 
are what remains afterwards [15] [16] [17].  
In conclusion, in this work, we present a 
patient with multiple entities in the aetiology of non-
catheter induced renal and vena cava thrombosis in a 
neonate. Clinicians should suspect renal vein 
thrombosis in neonates when presented with early 
postnatal gross hematuria, palpable abdominal mass 
and thrombopenia. Measures aimed at prevention of 
end-stage renal disease must be overtaken because 
of its poor outcome despite the anticoagulant 
treatment used. 
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